These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 26058757)
1. The association between breast cancer and thyroid cancer: a meta-analysis. Joseph KR; Edirimanne S; Eslick GD Breast Cancer Res Treat; 2015 Jul; 152(1):173-181. PubMed ID: 26058757 [TBL] [Abstract][Full Text] [Related]
2. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients. Grantzau T; Overgaard J Radiother Oncol; 2016 Dec; 121(3):402-413. PubMed ID: 27639892 [TBL] [Abstract][Full Text] [Related]
3. The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis. Nielsen SM; White MG; Hong S; Aschebrook-Kilfoy B; Kaplan EL; Angelos P; Kulkarni SA; Olopade OI; Grogan RH Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):231-8. PubMed ID: 26908594 [TBL] [Abstract][Full Text] [Related]
4. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Subramanian S; Goldstein DP; Parlea L; Thabane L; Ezzat S; Ibrahim-Zada I; Straus S; Brierley JD; Tsang RW; Gafni A; Rotstein L; Sawka AM Thyroid; 2007 Dec; 17(12):1277-88. PubMed ID: 18020916 [TBL] [Abstract][Full Text] [Related]
5. Risk of second primary malignancies in women with papillary thyroid cancer. Canchola AJ; Horn-Ross PL; Purdie DM Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240 [TBL] [Abstract][Full Text] [Related]
6. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study. Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627 [TBL] [Abstract][Full Text] [Related]
7. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel. Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430 [TBL] [Abstract][Full Text] [Related]
8. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies. Van Fossen VL; Wilhelm SM; Eaton JL; McHenry CR Ann Surg Oncol; 2013 Apr; 20(4):1341-7. PubMed ID: 23263698 [TBL] [Abstract][Full Text] [Related]
9. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. Verkooijen RB; Smit JW; Romijn JA; Stokkel MP Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748 [TBL] [Abstract][Full Text] [Related]
10. Nonendocrine cancers associated with benign and malignant parathyroid tumors. Fallah M; Kharazmi E; Sundquist J; Hemminki K J Clin Endocrinol Metab; 2011 Jul; 96(7):E1108-14. PubMed ID: 21525164 [TBL] [Abstract][Full Text] [Related]
11. Thyroid cancer as second primary malignancy in breast cancer patients. Sioka C; Fotopoulos A Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1604; author reply 1604. PubMed ID: 19306760 [No Abstract] [Full Text] [Related]
12. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429 [TBL] [Abstract][Full Text] [Related]
13. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Nandy N; Dasanu CA Curr Med Res Opin; 2013 Sep; 29(9):1055-65. PubMed ID: 23777310 [TBL] [Abstract][Full Text] [Related]
14. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database. Kuo JH; Chabot JA; Lee JA Surgery; 2016 Jan; 159(1):23-9. PubMed ID: 26522696 [TBL] [Abstract][Full Text] [Related]
16. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance]. Grundmann RT; Meyer F Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967 [TBL] [Abstract][Full Text] [Related]
17. Second primary malignancies following thyroid cancer: a population-based study in Taiwan. Lu CH; Lee KD; Chen PT; Chen CC; Kuan FC; Huang CE; Chen MF; Chen MC Eur J Endocrinol; 2013 Nov; 169(5):577-85. PubMed ID: 23939917 [TBL] [Abstract][Full Text] [Related]
18. Incidence of second primary malignancies in patients with thyroid cancer in the Turkish population. Karaköse M; Çordan İ; Can M; Kocabaş M; Kulaksızoğlu M; Karakurt F Turk J Med Sci; 2019 Oct; 49(5):1529-1533. PubMed ID: 31651125 [TBL] [Abstract][Full Text] [Related]
19. Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer. Consorti F; Di Tanna G; Milazzo F; Antonaci A World J Surg Oncol; 2011 Aug; 9():88. PubMed ID: 21835042 [TBL] [Abstract][Full Text] [Related]
20. Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Molina-Montes E; Requena M; Sánchez-Cantalejo E; Fernández MF; Arroyo-Morales M; Espín J; Arrebola JP; Sánchez MJ Gynecol Oncol; 2015 Jan; 136(1):158-71. PubMed ID: 25448459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]